India Chemotherapy at Home Service Market to be Dominated by Direct-to-Patient Services Segment through 2029
The expansion in tier-2 and tier-3 cities is
expected to drive the growth of India chemotherapy at home service market in
the forecast period, 2025-2029.
According to TechSci Research report, “India
Chemotherapy at Home
Service Market - By Region, Competition, Forecast and
Opportunities, 2029”, India chemotherapy
at home service market is anticipated to grow at an impressive rate in the
forecast period. This can be ascribed to the less risk involved when you
are treated at home rather than a hospital. Hospitals and clinics can be
sources of infections, especially for patients with weakened immune systems. By
receiving chemotherapy at home, patients are exposed to fewer people and have
less risk of contracting an infection. In a home setting, patients can receive
more personalized care, with medical professionals who are dedicated to their
treatment. This can help to identify and manage any complications that may
arise more quickly. Patients may feel more comfortable and relaxed in their own
home, which can help to reduce stress and anxiety, and may even contribute to
better treatment outcomes. Patients who receive chemotherapy at home may be
more likely to adhere to their treatment regimen since they do not have to
travel to a hospital or clinic, which can be time-consuming, anxious, and
stressful. With remote monitoring technology, medical professionals can monitor
patients continuously, which can help to identify any issues that may arise and
intervene quickly if necessary.
Major need of the chemotherapy at home service market is to grow focus
on quality and safety. Chemotherapy at home service providers must comply with
regulatory standards set by the government and healthcare authorities to ensure
that patients receive safe and effective care. Providers can obtain
accreditation and certification from independent organizations to demonstrate
their commitment to quality and safety. Providers must ensure that their staff
are trained and educated in best practices for administering chemotherapy at
home, including infection control, medication safety, and emergency response.
Providers must have processes in place to ensure that chemotherapy drugs are
stored and administered safely, and that patients receive the correct dosages
at the right times. Also, providers should seek feedback from patients to
identify areas for improvement and to ensure that patients are satisfied with
the care they receive.
Challenge
which is being faced by India chemotherapy
at home service market is resistance from healthcare providers. Many healthcare
providers may not be familiar with the concept of chemotherapy at home and may
be hesitant to adopt this new model of care. Healthcare providers may be concerned about the
potential liability associated with providing chemotherapy at home and may be
hesitant to take on this risk. Providers may
have concerns about reimbursement for chemotherapy at home services and may be
hesitant to invest resources in developing these services without a clear path
to reimbursement.
Browse over XX Market Data Figures spread
through XX Pages and an in-depth TOC on "India Chemotherapy at Home Service Market.”
India chemotherapy at home service market can be
segmented into by product, treatment stage, cancer type, distribution channel,
and region. By product, India chemotherapy at home service market can be
segmented into chemotherapy drugs and chemotherapy infusion pump. By treatment
stage, India chemotherapy at home service market can be segmented into early-stage
cancer, advanced-stage cancer, metastatic cancer, and recurrent cancer. By
cancer type, India chemotherapy at home service market can be segmented into breast
cancer, blood cancer, ovarian cancer, colorectal cancer, and others. By distribution
channel, India chemotherapy at home service market can be segmented into home
health agencies, pharmacy-based services, direct-to-patient services, and others.
By Region, India chemotherapy at home service market can be segmented into
North India, South India, East India, and West India.
Early-stage cancer refers to a cancer that is
localized to a specific part of the body and will not spread to other parts or
organs. In general, early-stage cancer is easier to treat and has a better
prognosis than cancer that has spread to other parts of the body. The staging
of cancer is based on the size and extent of the tumour, or whether the cancer
has spread to nearby lymph nodes or other organs. Staging is an important part
of determining the most appropriate treatment for an individual with cancer.
Chemotherapy can be an effective treatment for early-stage cancer when used in
combination with other treatments such as surgery and radiation therapy.
Chemotherapy is often used to kill cancer cells that may have spread beyond the
primary tumour, even when there are no visible signs of metastasis. Chemotherapy
can be administered at home by a trained healthcare professional, which can be
more convenient for patients and their families.
Based on the distribution channel, India chemotherapy at
home service market can be
segmented into home health agencies, pharmacy-based services, direct-to-patient
services, and others. Direct-to-patient services in India's chemotherapy at
home service market refer to the delivery of chemotherapy treatment and related
services directly to the patient's home, without the need for them to visit a
healthcare facility. In this model of care, healthcare providers, such as
oncologists and nurses, visit the patient's home to administer chemotherapy and
provide other services such as medical monitoring, symptom management, and
patient education. Patients may also receive support from other healthcare
professionals, such as pharmacists, who can deliver medications and supplies
directly to the patient's home. Direct-to-patient services can offer several
benefits to patients receiving chemotherapy, including increased convenience
and flexibility, reduced travel time and costs, and a more comfortable and
familiar environment to receive treatment. Direct-to-patient services are an
important and growing segment of the chemotherapy at home service market in
India, offering patients greater access to care and improved quality of life.
Major companies
operating in India chemotherapy at home service market are:
- Health Care at Home India Pvt Ltd.
- PurpleRibbon Healthcare Services Pvt Ltd.
- HCG Oncology Healthcare Pvt Ltd.
- Zoctr Health Pvt Ltd.
- Health Vista Pvt Ltd. (Portea Medical)
In 2021: Portea
Medical, a leading home healthcare provider in India, acquired Health Impetus,
a digital health startup that provides chronic disease management solutions,
including chemotherapy at home services.
In 2020: Max
Healthcare announced the launch of Max@ Home, a home healthcare service that
includes chemotherapy at home services.
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“India chemotherapy
at home service market is expected to dominate on account of the rising demand
for convenience and comfort with medical benefits along with growing preference
for personalized attention across the region. There are several home health agencies in India that offer chemotherapy
at home services. These agencies provide skilled nursing care, medical
equipment, medications, and other necessary services to patients in their
homes. These agencies typically employ trained and experienced healthcare
professionals, such as nurses and oncologists, who are trained to administer chemotherapy
and manage its side effects. Besides, increasing concern about healthy
lifestyles and increasing expenditure on health and wellness is further
expected to create lucrative opportunities for the market growth” said Mr.
Karan Chechi, Research Director with TechSci Research, a research based global
management consulting firm.
“India
Chemotherapy at Home Service Market, By Product (Chemotherapy Drugs and Chemotherapy
Infusion Pumps), By Treatment Stage (Early-Stage Cancer, Advanced-Stage Cancer,
Metastatic Cancer, and Recurrent Cancer), By Cancer Type (Breast Cancer,
Blood Cancer, Ovarian Cancer, Colorectal Cancer, and Others), By Distribution
Channel (Home Health Agencies, Pharmacy-based Services, Direct-to-Patient
Services, and Others), By Region, Competition, Forecast and Opportunities, 2029”, has evaluated the future
growth potential of India chemotherapy at home service market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India chemotherapy at home service market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com